IntelliDose®, a leading clinical software to manage medical oncology practices, today introduces IntelliScribe™ – a new, fully integrated module in the IntelliDose workflow – to electronically generate prescriptions at any point in the chemotherapy order writing process. IntelliScribe incorporates RelayHealth’s eScript™ to enable physicians to electronically file chemotherapy medication orders for the patient’s entire treatment regime.
“We spent time both evaluating ePrescribe applications and designing the IntelliScribe integration to provide a unique solution that fits into the complex workflow of an oncology practice.”
IntelliScribe works in tandem with IntelliDose to handle the prescriptions built into complex chemotherapy drug orders. Caregivers can electronically prescribe every aspect of a patient’s treatment – including pre-medications, intravenous chemotherapy doses, as well as take-home supportive medications, like antiemetics – in one seamless step. They can also specify oral chemotherapy as primary treatment or in combination with infused medications. Prescription information is automatically updated in the IntelliDose patient record.
Available in early 2010, IntelliScribe:
- Improves the efficiency of ordering all of the drugs around chemotherapy treatment
- Launches automatically from chemotherapy orders within IntelliDose workflow
- Allows users to submit prescriptions at any point during order review; before the patient arrives; while writing orders; or ready to send home with the patient
- Creates a complete, detailed record of the entire drug regimen
IntelliScribe complements existing e-prescribing solutions enabling any medications associated with the patient’s chemotherapy treatment to be prescribed directly from IntelliDose orders. At the same time, all prescription detail is seamlessly shared with any existing e-prescribing solution. For medical oncology practices that do not have e-prescribing, IntelliScribe can meet all prescription writing needs.